½ÃÀ庸°í¼­
»óǰÄÚµå
1372495

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ¸®Æ÷Æ® ¹üÀ§ : Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Vital Signs Monitoring Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 223 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2022³â¿¡ 256¾ï 1,700¸¸ ´Þ·¯, 2030³â¿¡´Â 668¾ï 2,400¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Ãß»êµÇµÇ¸ç, 2022-2030³âÀÇ CAGRÀº 12.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº Á¦Ç° Ãâ½Ã ¹× ½ÂÀÎ ¼ö Áõ°¡, ȯÀÚµéÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ ¼ö¿ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ±â¾÷ ¹× ±ÔÁ¦ ´ç±¹ÀÇ Á¦Ç° ȸ¼ö Á¶Ä¡°¡ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡

»ýü ½ÅÈ£ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â COVID-19°¡ À¯ÇàÇÒ ¶§ ±Þ°ÝÇÏ°Ô ±ÞÁõÇß½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹Í ±â°£ Áß ¸ÞµðÄÉ¾î ¾îµå¹êƼÁö(Medicare Advantage) û±¸°¡ ±ÞÁõÇߴµ¥, 2022³â 9¿ù Health AffairsÁö¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é COVID-19 ÆÒµ¥¹Í ±â°£ Áß ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ û±¸ °Ç¼ö°¡ 4¹è Áõ°¡ÇÏ¿© 2020³â 3¿ù 4, 355°Ç¿¡¼­ 2021³â 3¿ù 19,762°ÇÀ¸·Î Áõ°¡Çß½À´Ï´Ù. 355°Ç¿¡¼­ 2021³â 3¿ù¿¡´Â 19,762°Ç¿¡ ´ÞÇß½À´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº ȯÀÚÀÇ È°·Â ¡Èĸ¦ ¸ð´ÏÅ͸µÇÏ´Â ÀüÅëÀûÀÎ ¹æ¹ýÀ» ´ëüÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ÀÇ º¸±ÞÀº ÀçÅÃÄ¡·á ¼­ºñ½º Áõ°¡·Î À̾îÁ® ÀçÅÃÄ¡·á ÇöÀå¿¡¼­ ÆÞ½º¿Á½Ã¹ÌÅÍ, Ç÷¾Ð°è, ü¿Â°è µîÀÇ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Áö³­ ¼ö³â°£ ÀçÅÃÄ¡·á´Â ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÇ È¿À²¼º°ú ºñ¿ë È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ³ëÀÎ Àα¸¿Í º´¿ø Ä¡·á ÈÄ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ÁßÁõ ȯÀÚµéÀ» À§ÇÑ ÀçÅÃÄ¡·á ȯ°æ¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¹«¼± ±â¼ú°ú ¿þ¾î·¯ºí ±â±â µîÀÇ ¹ßÀüÀ¸·Î ÀÇ·áÁø °£ »óÈ£¿î¿ë¼º°ú ȯÀÚ °£ È®À强ÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ½ÉÀå »óÅÂ, üÁß º¯È­, Ç÷¾Ð, ¼ö¸é¹«È£ÈíÁõ, õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ µîÀ» ½±°Ô ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ COVID-19 À§±â µ¿¾È ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ º¯È­Çϸ鼭 ¿ø°Ý Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ ÀåºñÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ »ç¿ëÀº º´¿ø ¹æ¹® ºóµµ¸¦ Å©°Ô °¨¼Ò½ÃÄÑ ÀÇ·á ÀÚ¿ø Ȱ¿ëÀ» ÃÖÀûÈ­Çϰí ÀǷḦ º¸´Ù Áö¼Ó°¡´ÉÇÏ°Ô ¸¸µé¾ú½À´Ï´Ù. ¶ÇÇÑ ¼Ò¼È¹Ìµð¾îÀÇ ¿µÇâ°ú ÀÇ·á ½Ã¼³ÀÇ È£ÀÇÀûÀÎ ³ë·ÂÀ¸·Î ÀÎÇØ Áö¹æ°ú µµ½Ã Áö¿ª »ç¶÷µéÀÌ ¿ø°ÝÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ³½À´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÎ¹®º° °³¿ä

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀº Á¦Ç° ¹× ÃÖÁ¾»ç¿ëÀÚº°·Î ºÐ¼®µË´Ï´Ù. Á¦Ç° ±âÁØÀ¸·Î´Â ÆÞ½º¿Á½Ã¹ÌÅÍ, Ç÷¾Ð ¸ð´ÏÅÍ, ü¿Â ¸ð´ÏÅÍ, Ç÷´ç ¸ð´ÏÅ͸µ ±â±â·Î ºÐ·ùµÇ¸ç, 2022³â¿¡´Â Æ÷µµ´ç ¸ð´ÏÅÍ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí 2022-2030³â¿¡´Â ÆÞ½º¿Á½Ã¹ÌÅÍ ºÎ¹®ÀÌ °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÆÞ½º¿Á½Ã¹ÌÅʹ Ź»óÇü/Ãø¸éÇü ÆÞ½º¿Á½Ã¹ÌÅÍ, ÈÞ´ë¿ë ÆÞ½º¿Á½Ã¹ÌÅÍ, ÆÞ½º¿Á½Ã¹ÌÅÍ ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù. ¸¶Âù°¡Áö·Î Ç÷¾Ð°è ºÎ¹®Àº ¼öÀº Ç÷¾Ð°è, ¿Ü·¡ Ç÷¾Ð°è, µðÁöÅÐ Ç÷¾Ð°è, ¾Æ³¯·Î±× Ç÷¾Ð°è, Ç÷¾Ð°è ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù. ¸¶Âù°¡Áö·Î ü¿Â ¸ð´ÏÅ͸µ Àåºñ ºÎ¹®Àº ¼öÀº ÃæÀü ¿Âµµ°è, µðÁöÅÐ ¿Âµµ°è, Àû¿Ü¼± ¿Âµµ°è, ¾×Á¤ ¿Âµµ°è, ü¿Â ¸ð´ÏÅ͸µ Àåºñ ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù. ¶ÇÇÑ Æ÷µµ´ç ¸ð´ÏÅÍ´Â ÀÚ°¡ Æ÷µµ´ç ¸ð´ÏÅÍ¿Í ¿¬¼Ó Æ÷µµ´ç ¸ð´ÏÅÍ·Î ¼¼ºÐÈ­µË´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á, ±âŸ·Î ºÐ·ùµÇ¸ç, 2022³â¿¡´Â º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀçÅÃÄ¡·á ºÐ¾ß´Â 2022-2030³â °¡Àå ºü¸¥ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð Áõ°¡, ÀçÅÃÄ¡·á ȯ°æ¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ÀÇ·á±â±â ¿¬±¸ ¹× °³¹ß Áõ°¡´Â Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå Áö¿ªº° °³¿ä

Áö¿ªº°·Î´Â ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀåÀ» ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì·Î ³ª´©¾î ºÐ¼®Çϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀåÀÇ ÃÖ´ë ½ÃÀåÀ̸ç, À¯·´ÀÌ ±Þ¼ºÀå Áö¿ªÀÔ´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ÁÖ¿ä ±â¾÷

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Á¶»ç¿¡¼­´Â Koninklijke Philips NV, Medtronic Plc, ´ÏÈ¥ÄÚµ§»ê¾÷, GE HealthCare Technologies Inc, OMRON Corp, Nonin Medical Inc, SunTech Medical Inc, Masimo Corp, Contec Medical Systems Co Ltd, Baxter International Inc. µîÀÇ ÁÖ¿ä ±â¾÷ÀÌ ºÐ¼® µÇ¾ú½À´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡ °üÇÑ ¸®Æ÷Æ® ÀÛ¼º½Ã ÂüÁ¶ÇÑ ÁÖ¿ä 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¿¡´Â ¼¼°èº¸°Ç±â±¸(WHO), FDA(½ÄǰÀǾ౹), µ¶ÀÏ ¿¬¹æ ±³À° ¿¬±¸¼º, ±¹Á¦´ç´¢º´¿¬¸Í(IDF) µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

  • ´ë»ó ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ±¸µµ

  • °³¿ä
  • PEST ºÐ¼®
    • ¼¼°èÀÇ PEST ºÐ¼®
  • º¥´õ ¸®½ºÆ®
    • ¹ë·ùüÀÎ º¥´õ ¸®½ºÆ®

Á¦5Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ
    • Á¦Ç° Ãâ½Ã ¼ö¿Í ½ÂÀÎ ¼öÀÇ Áõ°¡
    • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¿ä±¸ÀÇ Áõ°¡
  • ÁÖ¿ä ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ±â¾÷ ¹× ±ÔÁ¦±â°ü¿¡ ÀÇÇÑ Á¦Ç° ¸®ÄÝ
  • ÁÖ¿ä ½ÃÀå ±âȸ
    • ½Ç½Ã°£ Åë½Å ±â´ÉÀÇ ÅëÇÕ
  • ÇâÈÄ µ¿Çâ
    • ÇコÄɾ¼­ ·¹ÀÌ´õ ±â¼úÀÇ ÀÌ¿ë
  • ¿µÇ⠺м®

Á¦6Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

  • ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ¸ÅÃâ, 2022-2030³â

Á¦7Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå - 2030³â±îÁöÀÇ ¸ÅÃâ°ú ¿¹Ãø : Á¦Ç°º°

  • ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : 2022³â¡¤2030³â Á¦Ç°º° ÆÇ¸Å°í Á¡À¯À²(%)
  • ÆÞ½º ¿Á½Ã¹ÌÅÍ
  • Ç÷¾Ð ¸ð´ÏÅÍ
  • ü¿Â ¸ð´ÏÅ͸µ ±â±â
  • ±Û·çÄÚ¿À½º ¸ð´ÏÅ͸µ µð¹ÙÀ̽º

Á¦8Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ°ú 2030³â±îÁöÀÇ ¿¹Ãø

  • ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ÆÇ¸Å°í Á¡À¯À²(2022³â¡¤2030³â)
  • º´¿ø ¹× Áø·á¼Ò
  • ¿Ü·¡ ÀÇ·á ¼¾ÅÍ
  • ȨÇコÄɾî
  • ±âŸ

Á¦9Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå - Áö¿ª ºÐ¼®

    • ºÏ¹Ì : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°
      • ºÏ¹Ì : ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå
      • ºÏ¹Ì : Ç÷¾Ð ¸ð´ÏÅÍ ½ÃÀå
      • ºÏ¹Ì : ¿Âµµ ¸ð´ÏÅÍ ½ÃÀå
      • ºÏ¹Ì : ±Û·çÄÚ¿À½º ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå
    • ºÏ¹Ì : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
    • ºÏ¹Ì : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
    • À¯·´ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°
      • À¯·´ ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå
      • À¯·´ : Ç÷¾Ð ¸ð´ÏÅÍ ½ÃÀå
      • À¯·´ ü¿Â ¸ð´ÏÅÍ ½ÃÀå
      • À¯·´ ±Û·çÄÚ¿À½º ¸ð´ÏÅÍ ½ÃÀå
    • À¯·´ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅÍ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
    • À¯·´ÀÇ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ±¹°¡º°
      • ¿µ±¹
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°
      • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå
      • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷¾Ð ¸ð´ÏÅÍ ½ÃÀå
      • ¾Æ½Ã¾ÆÅÂÆò¾ç : ü¿Â ¸ð´ÏÅ͸µ Àåºñ ½ÃÀå
      • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±Û·çÄÚ¿À½º ¸ð´ÏÅÍ ½ÃÀå
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áßµ¿ & ¾ÆÇÁ¸®Ä« : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°
      • Áßµ¿ & ¾ÆÇÁ¸®Ä« : ÆÞ½º ¿Á½Ã¹ÌÅÍ ½ÃÀå
      • Áßµ¿ & ¾ÆÇÁ¸®Ä« : Ç÷¾Ð ¸ð´ÏÅÍ ½ÃÀå
      • Áßµ¿ & ¾ÆÇÁ¸®Ä« : ¿Âµµ ¸ð´ÏÅÍ ½ÃÀå
      • Áßµ¿ & ¾ÆÇÁ¸®Ä« : ±Û·çÄÚ¿À½º ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå
    • Áßµ¿ & ¾ÆÇÁ¸®Ä« : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
    • Áßµ¿ & ¾ÆÇÁ¸®Ä« : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ±¹°¡º°
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ¾Æ¶ø¿¡¹Ì¸®Æ®
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áß³²¹Ì : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°
      • Áß³²¹Ì : ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå
      • Áß³²¹Ì : Ç÷¾Ð ¸ð´ÏÅÍ ½ÃÀå
      • Áß³²¹Ì : ¿Âµµ ¸ð´ÏÅÍ ½ÃÀå
      • Áß³²¹Ì : ±Û·çÄÚ¿À½º ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå
    • Áß³²¹Ì : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
    • Áß³²¹Ì : ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ³²¹Ì ±¹°¡

Á¦10Àå COVID-19 ÀüÈÄÀÇ ¿µÇâ

  • COVID-19 ÀüÈÄÀÇ ¿µÇâ

Á¦11Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅÍ ½ÃÀå - ¾÷°è »óȲ

  • À¯±âÀû ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Koninklijke Philips NV
  • Medtronic Plc
  • Nihon Kohden Corp
  • GE HealthCare Technologies Inc
  • OMRON Corp
  • Nonin Medical Inc
  • SunTech Medical Inc
  • Masimo Corp
  • Contec Medical Systems Co Ltd
  • Baxter International Inc

Á¦13Àå ºÎ·Ï

KSA 23.11.08

The vital signs monitoring devices market is estimated to reach US$ 25.617 billion in 2022 to US$ 66.824 billion by 2030; the market is projected to record a CAGR of 12.7% from 2022 to 2030.

Some of the key driving factors for the vital signs monitoring devices market growth are the increasing number of product launches and approvals and rise in need for remote patient monitoring. However, product recalls by companies and regulatory authorities are hindering market growth.

Rise in Need for Remote Patient Monitoring

The demand for vital signs monitoring devices surged exponentially during the COVID-19 pandemic. Moreover, there was a sudden increase in Medicare Advantage claims during the COVID-19 pandemic. As per a survey published in Health Affairs in September 2022, claims for remote patient monitoring grew by four times during the COVID-19 pandemic, reaching 19,762 claims in March 2021 from 4,355 claims in March 2020. Remote patient monitoring has replaced conventional methods of monitoring patients' vital signs. The popularity of digital health has led to a rise in home care services, creating tremendous demand for devices such as pulse oximeters, BP monitors, and thermometers in homecare settings. Home healthcare has led to enhanced efficiency and cost-effectiveness in healthcare systems worldwide in the last few years. Similarly, the demand for remote patient monitoring increases with the growing preference for home care settings for the geriatric population and for people with critical conditions who require monitoring post-hospital care.

Advancements such as wireless technologies and wearable devices have improved interoperability among healthcare professionals and scalability among patients. These devices have made it easy to monitor heart conditions, weight gain/loss, blood pressure, sleep apnea, asthma, and chronic obstructive pulmonary disease. In addition, the requirement for remote vital signs monitoring devices grew during the COVID-19 crisis owing to a shift in consumer preference toward telehealth. The use of telehealth resulted in a significant decrease in the frequency of hospital visits and optimized the use of healthcare resources, making healthcare more sustainable. Additionally, people in rural and urban areas are becoming highly aware of telehealth services due to the influence of social media and favorable initiatives by healthcare facilities.

Vital Signs Monitoring Devices Market: Segmental Overview

The vital signs monitoring devices market is analyzed on the product and end user. On the basis product, the market is segmented into pulse oximeter, blood pressure monitors, temperature monitoring devices, and glucose monitoring devices. In 2022, the glucose monitors segment held the largest market share, during 2022-2030 the pulse oximeters segment is anticipated to grow with a fastest growth rate. Further, pulse oximeter is subsegmented into table-top/beside pulse oximeters, hand-held pulse oximeters, and pulse oximeter accessories. Similarly, blood pressure monitors segment is subsegmented into mercury blood pressure monitors, ambulatory blood pressure monitors, digital blood pressure monitors, analog blood pressure monitors, and blood pressure instrument accessories. Likewise, temperature monitoring devices segment is subsegmented into mercury filled thermometers, digital thermometers, infrared thermometers liquid crystal thermometers, and temperature monitoring device accessories. And based on glucose monitors is subsegmeneted into self glucose monitors and continuous glucose monitors.

On the basis of end user, the market is classified into hospitals & clinics, ambulatory surgical centers, home healthcare, and others. In 2022, the hospitals and clinics segment held the largest market share holder. The home healthcare segment is estimated to register the fastest CAGR during 2022-2030. The increasing number of hospitals and clinics, surging preference for home healthcare settings, and rising R&D in medical devices are the key factors contributing to the growth of the vital signs monitoring devices market.

Vital Signs Monitoring Devices Market: Geographical Overview

Based on geography, the vital signs monitoring devices market is analyzed for North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. Based on regions, North America is the largest market for vital signs monitoring devices market, and Europe is the fastest-growing region.

Vital Signs Monitoring Devices Market: Key Players

Under the vital signs monitoring devices market study, a few key players were analyzed, which include Koninklijke Philips NV, Medtronic Plc, Nihon Kohden Corp, GE HealthCare Technologies Inc, OMRON Corp, Nonin Medical Inc, SunTech Medical Inc, Masimo Corp, Contec Medical Systems Co Ltd, and Baxter International Inc.

A few of the key primary and secondary sources referred to while preparing the report on the vital signs monitoring devices market are the World Health Organization (WHO), FDA (Food and Drug Administration), German Federal Ministry of Education and Research, and International Diabetes Federation (IDF).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the vital signs monitoring devices.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global vital signs monitoring devices, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global vital signs monitoring devices trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Vital Signs Monitoring Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis
  • 4.3 List of Vendors
    • 4.3.1 List of Vendors in the Value Chain

5. Vital Signs Monitoring Devices Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Number of Product Launches and Approvals
    • 5.1.2 Rise in Need for Remote Patient Monitoring
  • 5.2 Key Market Restraints:
    • 5.2.1 Product Recalls by Companies and Regulatory Authorities
  • 5.3 Key Market Opportunities:
    • 5.3.1 Integration of Real-Time Communication Feature
  • 5.4 Future Trends
    • 5.4.1 Use of Radar Technology in Healthcare
  • 5.5 Impact Analysis:

6. Vital Signs Monitoring Devices Market - Global Market Analysis

  • 6.1 Vital Signs Monitoring Devices Market Revenue (US$ Mn), 2022 - 2030

7. Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Vital Signs Monitoring Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Pulse Oximeters
    • 7.3.1 Overview
    • 7.3.2 Pulse Oximeters: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Table-top/Beside Pulse Oximeters
      • 7.3.3.1 Overview
      • 7.3.3.2 Table-top/Beside Pulse Oximeters: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Hand-held Pulse Oximeters
      • 7.3.4.1 Overview
      • 7.3.4.2 Hand-held Pulse Oximeters: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Pulse Oximeter Accessories
      • 7.3.5.1 Overview
      • 7.3.5.2 Pulse Oximeter Accessories: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Blood Pressure Monitors
    • 7.4.1 Overview
    • 7.4.2 Blood Pressure Monitors: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 Mercury Blood Pressure Monitors
      • 7.4.3.1 Overview
      • 7.4.3.2 Mercury Blood Pressure Monitors: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Ambulatory Blood Pressure Monitors
      • 7.4.4.1 Overview
      • 7.4.4.2 Ambulatory Blood Pressure Monitors: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.5 Digital Blood Pressure Monitors
      • 7.4.5.1 Overview
      • 7.4.5.2 Digital Blood Pressure Monitors: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.6 Analog Blood Pressure Monitors
      • 7.4.6.1 Overview
      • 7.4.6.2 Analog Blood Pressure Monitors: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.7 Blood Pressure Instrument Accessories
      • 7.4.7.1 Overview
      • 7.4.7.2 Blood Pressure Instrument Accessories: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Temperature Monitoring Devices
    • 7.5.1 Overview
    • 7.5.2 Temperature Monitoring Devices: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.3 Mercury Filled Thermometers
      • 7.5.3.1 Overview
      • 7.5.3.2 Mercury Filled Thermometers: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.4 Digital Thermometers
      • 7.5.4.1 Overview
      • 7.5.4.2 Digital Thermometers: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.5 Infrared Thermometers
      • 7.5.5.1 Overview
      • 7.5.5.2 Infrared Thermometers: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.6 Liquid Crystal Thermometers
      • 7.5.6.1 Overview
      • 7.5.6.2 Liquid Crystal Thermometers: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Glucose Monitoring Devices
    • 7.6.1 Overview
    • 7.6.2 Glucose Monitoring Devices: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.3 Self Glucose Monitoring Devices
      • 7.6.3.1 Overview
      • 7.6.3.2 Self Glucose Monitoring Devices: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.4 Continuous Glucose Monitoring Devices
      • 7.6.4.1 Overview
      • 7.6.4.2 Continuous Glucose Monitoring Devices: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Vital Signs Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals and Clinics
    • 8.3.1 Overview
    • 8.3.2 Hospitals and Clinics: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ambulatory Care Centers
    • 8.4.1 Overview
    • 8.4.2 Ambulatory Care Centers: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Home Healthcare
    • 8.5.1 Overview
    • 8.5.2 Home Healthcare: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Vital Signs Monitoring Devices Market - Regional Analysis

  • 9.1 North America Vital Signs Monitoring Devices Market, Revenue and Forecast To 2030
    • 9.1.1 Overview
    • 9.1.2 Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.1.3 North America: Vital Signs Monitoring Devices Market, by Product
      • 9.1.3.1 North America: Pulse Oximeters Market
      • 9.1.3.2 North America: Blood Pressure Monitors Market
      • 9.1.3.3 North America: Temperature Monitoring Devices Market
      • 9.1.3.4 North America: Glucose Monitoring Devices Market
    • 9.1.4 North America: Vital Signs Monitoring Devices Market, by End User
    • 9.1.5 North America: Vital Signs Monitoring Devices Market, by Country
      • 9.1.5.1 US
        • 9.1.5.1.1 Overview
        • 9.1.5.1.2 US: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.5.1.3 US: Vital Signs Monitoring Devices Market, by Product
        • 9.1.5.1.3.1 US: Pulse Oximeters Market
        • 9.1.5.1.3.2 US: Blood Pressure Monitors Market
        • 9.1.5.1.3.3 US: Temperature Monitoring Devices Market
        • 9.1.5.1.4 US: Vital Signs Monitoring Devices Market, by End User
      • 9.1.5.2 Canada
        • 9.1.5.2.1 Overview
        • 9.1.5.2.2 Canada: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.5.2.3 Canada: Vital Signs Monitoring Devices Market, by Product
        • 9.1.5.2.3.1 Canada: Pulse Oximeters Market
        • 9.1.5.2.3.2 Canada: Blood Pressure Monitors Market
        • 9.1.5.2.3.3 Canada: Temperature Monitoring Devices Market
        • 9.1.5.2.3.4 Canada: Glucose Monitoring Devices Market
        • 9.1.5.2.4 Canada: Vital Signs Monitoring Devices Market, by End User
      • 9.1.5.3 Mexico
        • 9.1.5.3.1 Overview
        • 9.1.5.3.2 Mexico: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.5.3.3 Mexico: Vital Signs Monitoring Devices Market, by Product
        • 9.1.5.3.3.1 Mexico: Pulse Oximeters Market
        • 9.1.5.3.3.2 Mexico: Blood Pressure Monitors Market
        • 9.1.5.3.3.3 Mexico: Temperature Monitoring Devices Market
        • 9.1.5.3.3.4 Mexico: Glucose Monitoring Devices Market
        • 9.1.5.3.4 Mexico: Vital Signs Monitoring Devices Market, by End User
  • 9.2 Europe Vital Signs Monitoring Devices Market, Revenue and Forecast To 2030
    • 9.2.1 Overview
    • 9.2.2 Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.2.3 Europe: Vital Signs Monitoring Devices Market, by Product
      • 9.2.3.1 Europe: Pulse Oximeters Market
      • 9.2.3.2 Europe: Blood Pressure Monitors Market
      • 9.2.3.3 Europe: Temperature Monitoring Devices Market
      • 9.2.3.4 Europe: Glucose Monitors Market
    • 9.2.4 Europe: Vital Signs Monitoring Devices Market, by End User
    • 9.2.5 Europe: Vital Signs Monitoring Devices Market, by Country
      • 9.2.5.1 UK
        • 9.2.5.1.1 UK: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.1.2 UK: Vital Signs Monitoring Devices Market, by Product
        • 9.2.5.1.2.1 UK: Pulse Oximeters Market
        • 9.2.5.1.2.2 UK: Blood Pressure Monitors Market
        • 9.2.5.1.2.3 UK: Temperature Monitoring Devices Market
        • 9.2.5.1.2.4 UK: Glucose Monitors Market
        • 9.2.5.1.3 UK: Vital Signs Monitoring Devices Market, by End User
      • 9.2.5.2 Germany
        • 9.2.5.2.1 Germany: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.2.2 Germany: Vital Signs Monitoring Devices Market, by Product
        • 9.2.5.2.2.1 Germany: Pulse Oximeters Market
        • 9.2.5.2.2.2 Germany: Blood Pressure Monitors Market
        • 9.2.5.2.2.3 Germany: Temperature Monitoring Devices Market
        • 9.2.5.2.2.4 Germany: Glucose Monitors Market
        • 9.2.5.2.3 Germany: Vital Signs Monitoring Devices Market, by End User
      • 9.2.5.3 France
        • 9.2.5.3.1 France: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.3.2 France: Vital Signs Monitoring Devices Market, by Product
        • 9.2.5.3.2.1 France: Pulse Oximeters Market
        • 9.2.5.3.2.2 France: Blood Pressure Monitors Market
        • 9.2.5.3.2.3 France: Temperature Monitoring Devices Market
        • 9.2.5.3.2.4 France: Glucose Monitors Market
        • 9.2.5.3.3 France: Vital Signs Monitoring Devices Market, by End User
      • 9.2.5.4 Italy
        • 9.2.5.4.1 Italy: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.4.2 Italy: Vital Signs Monitoring Devices Market, by Product
        • 9.2.5.4.2.1 Italy: Pulse Oximeters Market
        • 9.2.5.4.2.2 Italy: Blood Pressure Monitors Market
        • 9.2.5.4.2.3 Italy: Temperature Monitoring Devices Market
        • 9.2.5.4.2.4 Italy: Glucose Monitors Market
        • 9.2.5.4.3 Italy: Vital Signs Monitoring Devices Market, by End User
      • 9.2.5.5 Spain
        • 9.2.5.5.1 Spain: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.5.2 Spain: Vital Signs Monitoring Devices Market, by Product
        • 9.2.5.5.2.1 Spain: Pulse Oximeters Market
        • 9.2.5.5.2.2 Spain: Blood Pressure Monitors Market
        • 9.2.5.5.2.3 Spain: Temperature Monitoring Devices Market
        • 9.2.5.5.2.4 Spain: Glucose Monitors Market
        • 9.2.5.5.3 Spain: Vital Signs Monitoring Devices Market, by End User
      • 9.2.5.6 Rest of Europe
        • 9.2.5.6.1 Rest of Europe: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.6.2 Rest of Europe: Vital Signs Monitoring Devices Market, by Product
        • 9.2.5.6.2.1 Rest of Europe: Pulse Oximeters Market
        • 9.2.5.6.2.2 Rest of Europe: Blood Pressure Monitors Market
        • 9.2.5.6.2.3 Rest of Europe: Temperature Monitoring Devices Market
        • 9.2.5.6.2.4 Rest of Europe: Glucose Monitors Market
        • 9.2.5.6.3 Rest of Europe: Vital Signs Monitoring Devices Market, by End User
  • 9.3 Asia Pacific Vital Signs Monitoring Devices Market, Revenue and Forecast To 2030
    • 9.3.1 Overview
    • 9.3.2 Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.3.3 Asia Pacific: Vital Signs Monitoring Devices Market, by Product
      • 9.3.3.1 Asia Pacific: Pulse Oximeters Market
      • 9.3.3.2 Asia Pacific: Blood Pressure Monitors Market
      • 9.3.3.3 Asia Pacific: Temperature Monitoring Devices Market
      • 9.3.3.4 Asia Pacific: Glucose Monitors Market
    • 9.3.4 Asia Pacific: Vital Signs Monitoring Devices Market, by End User
    • 9.3.5 Asia Pacific: Vital Signs Monitoring Devices Market, by Country
      • 9.3.5.1 China
        • 9.3.5.1.1 China: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.1.2 China: Vital Signs Monitoring Devices Market, by Product
        • 9.3.5.1.2.1 China: Pulse Oximeters Market
        • 9.3.5.1.2.2 China: Blood Pressure Monitors Market
        • 9.3.5.1.2.3 China: Temperature Monitoring Devices Market
        • 9.3.5.1.2.4 China: Glucose Monitors Market
        • 9.3.5.1.3 China: Vital Signs Monitoring Devices Market, by End User
      • 9.3.5.2 Japan
        • 9.3.5.2.1 Japan: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.2.2 Japan: Vital Signs Monitoring Devices Market, by Product
        • 9.3.5.2.2.1 Japan: Pulse Oximeters Market
        • 9.3.5.2.2.2 Japan: Blood Pressure Monitors Market
        • 9.3.5.2.2.3 Japan: Temperature Monitoring Devices Market
        • 9.3.5.2.2.4 Japan: Glucose Monitors Market
        • 9.3.5.2.3 Japan: Vital Signs Monitoring Devices Market, by End User
      • 9.3.5.3 India
        • 9.3.5.3.1 India: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.3.2 India: Vital Signs Monitoring Devices Market, by Product
        • 9.3.5.3.2.1 India: Pulse Oximeters Market
        • 9.3.5.3.2.2 India: Blood Pressure Monitors Market
        • 9.3.5.3.2.3 India: Temperature Monitoring Devices Market
        • 9.3.5.3.2.4 India: Glucose Monitors Market
        • 9.3.5.3.3 India: Vital Signs Monitoring Devices Market, by End User
      • 9.3.5.4 Australia
        • 9.3.5.4.1 Australia: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.4.2 Australia: Vital Signs Monitoring Devices Market, by Product
        • 9.3.5.4.2.1 Australia: Pulse Oximeters Market
        • 9.3.5.4.2.2 Australia: Blood Pressure Monitors Market
        • 9.3.5.4.2.3 Australia: Temperature Monitoring Devices Market
        • 9.3.5.4.2.4 Australia: Glucose Monitors Market
        • 9.3.5.4.3 Australia: Vital Signs Monitoring Devices Market, by End User
      • 9.3.5.5 South Korea
        • 9.3.5.5.1 South Korea: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.5.2 South Korea: Vital Signs Monitoring Devices Market, by Product
        • 9.3.5.5.2.1 South Korea: Pulse Oximeters Market
        • 9.3.5.5.2.2 South Korea: Blood Pressure Monitors Market
        • 9.3.5.5.2.3 South Korea: Temperature Monitoring Devices Market
        • 9.3.5.5.2.4 South Korea: Glucose Monitors Market
        • 9.3.5.5.3 South Korea: Vital Signs Monitoring Devices Market, by End User
      • 9.3.5.6 Rest of Asia Pacific
        • 9.3.5.6.1 Rest of Asia Pacific: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.6.2 Rest of Asia Pacific: Vital Signs Monitoring Devices Market, by Product
        • 9.3.5.6.2.1 Rest of Asia Pacific: Pulse Oximeters Market
        • 9.3.5.6.2.2 Rest of Asia Pacific: Blood Pressure Monitors Market
        • 9.3.5.6.2.3 Rest of Asia Pacific: Temperature Monitoring Devices Market
        • 9.3.5.6.2.4 Rest of Asia Pacific: Glucose Monitors Market
        • 9.3.5.6.3 Rest of Asia Pacific: Vital Signs Monitoring Devices Market, by End User
  • 9.4 Middle East & Africa Vital Signs Monitoring Devices Market, Revenue and Forecast To 2030
    • 9.4.1 Overview
    • 9.4.2 Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.4.3 Middle East & Africa: Vital Signs Monitoring Devices Market, by Product
      • 9.4.3.1 Middle East & Africa: Pulse Oximeters Market
      • 9.4.3.2 Middle East & Africa: Blood Pressure Monitors Market
      • 9.4.3.3 Middle East & Africa: Temperature Monitoring Devices Market
      • 9.4.3.4 Middle East & Africa: Glucose Monitoring Devices Market
    • 9.4.4 Middle East & Africa: Vital Signs Monitoring Devices Market, by End User
    • 9.4.5 Middle East & Africa: Vital Signs Monitoring Devices Market, by Country
      • 9.4.5.1 Saudi Arabia
        • 9.4.5.1.1 Overview
        • 9.4.5.1.2 Saudi Arabia: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.1.3 Saudi Arabia: Vital Signs Monitoring Devices Market, by Product
        • 9.4.5.1.3.1 Saudi Arabia: Pulse Oximeters Market
        • 9.4.5.1.3.2 Saudi Arabia: Blood Pressure Monitors Market
        • 9.4.5.1.3.3 Saudi Arabia: Temperature Monitoring Devices Market
        • 9.4.5.1.3.4 Saudi Arabia: Glucose Monitoring Devices Market
        • 9.4.5.1.4 Saudi Arabia: Vital Signs Monitoring Devices Market, by End User
      • 9.4.5.2 UAE
        • 9.4.5.2.1 Overview
        • 9.4.5.2.2 UAE: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.2.3 UAE: Vital Signs Monitoring Devices Market, by Product
        • 9.4.5.2.3.1 UAE: Pulse Oximeters Market
        • 9.4.5.2.3.2 UAE: Blood Pressure Monitors Market
        • 9.4.5.2.3.3 UAE: Temperature Monitoring Devices Market
        • 9.4.5.2.3.4 UAE: Glucose Monitoring Devices Market
        • 9.4.5.2.4 UAE: Vital Signs Monitoring Devices Market, by End User
      • 9.4.5.3 South Africa
        • 9.4.5.3.1 Overview
        • 9.4.5.3.2 South Africa: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.3.3 South Africa: Vital Signs Monitoring Devices Market, by Product
        • 9.4.5.3.3.1 South Africa: Pulse Oximeters Market
        • 9.4.5.3.3.2 South Africa: Blood Pressure Monitors Market
        • 9.4.5.3.3.3 South Africa: Temperature Monitoring Devices Market
        • 9.4.5.3.3.4 South Africa: Glucose Monitoring Devices Market
        • 9.4.5.3.4 South Africa: Vital Signs Monitoring Devices Market, by End User
      • 9.4.5.4 Rest of Middle East & Africa
        • 9.4.5.4.1 Overview
        • 9.4.5.4.2 Rest of Middle East & Africa: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.4.3 Rest of Middle East & Africa: Vital Signs Monitoring Devices Market, by Product
        • 9.4.5.4.3.1 Rest of Middle East & Africa: Pulse Oximeters Market
        • 9.4.5.4.3.2 Rest of Middle East & Africa: Blood Pressure Monitors Market
        • 9.4.5.4.3.3 Rest of Middle East & Africa: Temperature Monitoring Devices Market
        • 9.4.5.4.3.4 Rest of Middle East & Africa: Glucose Monitoring Devices Market
        • 9.4.5.4.4 Rest of Middle East & Africa: Vital Signs Monitoring Devices Market, by End User
  • 9.5 South & Central America Vital Signs Monitoring Devices Market, Revenue and Forecast To 2030
    • 9.5.1 Overview
    • 9.5.2 Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.5.3 South & Central America: Vital Signs Monitoring Devices Market, by Product
      • 9.5.3.1 South & Central America: Pulse Oximeters Market
      • 9.5.3.2 South & Central America: Blood Pressure Monitors Market
      • 9.5.3.3 South & Central America: Temperature Monitoring Devices Market
      • 9.5.3.4 South & Central America: Glucose Monitoring Devices Market
    • 9.5.4 South & Central America: Vital Signs Monitoring Devices Market, by End User
    • 9.5.5 South & Central America: Vital Signs Monitoring Devices Market, by Country
      • 9.5.5.1 Brazil
        • 9.5.5.1.1 Overview
        • 9.5.5.1.2 Brazil: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.1.3 Brazil: Vital Signs Monitoring Devices Market, by Product
        • 9.5.5.1.3.1 Brazil: Pulse Oximeters Market
        • 9.5.5.1.3.2 Brazil: Blood Pressure Monitors Market
        • 9.5.5.1.3.3 Brazil: Temperature Monitoring Devices Market
        • 9.5.5.1.3.4 Brazil: Glucose Monitoring Devices Market
        • 9.5.5.1.4 Brazil: Vital Signs Monitoring Devices Market, by End User
      • 9.5.5.2 Argentina
        • 9.5.5.2.1 Overview
        • 9.5.5.2.2 Argentina: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.2.3 Argentina: Vital Signs Monitoring Devices Market, by Product
        • 9.5.5.2.3.1 Argentina: Pulse Oximeters Market
        • 9.5.5.2.3.2 Argentina: Blood Pressure Monitors Market
        • 9.5.5.2.3.3 Argentina: Temperature Monitoring Devices Market
        • 9.5.5.2.3.4 Argentina: Glucose Monitoring Devices Market
        • 9.5.5.2.4 Argentina: Vital Signs Monitoring Devices Market, by End User
      • 9.5.5.3 Rest of South & Central America
        • 9.5.5.3.1 0verview
        • 9.5.5.3.2 Rest of South & Central America: Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.3.3 Rest of South & Central America: Vital Signs Monitoring Devices Market, by Product
        • 9.5.5.3.3.1 Rest of South & Central America: Pulse Oximeters Market
        • 9.5.5.3.3.2 Rest of South & Central America: Blood Pressure Monitors Market
        • 9.5.5.3.3.3 Rest of South & Central America: Temperature Monitoring Devices Market
        • 9.5.5.3.3.4 Rest of South & Central America: Glucose Monitoring Devices Market
        • 9.5.5.3.4 Rest of South & Central America: Vital Signs Monitoring Devices Market, by End User

10. Pre & Post Covid-19 Impact

  • 10.1 Pre & Post Covid-19 Impact

11. Vital Signs Monitoring Devices Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Koninklijke Philips NV
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Nihon Kohden Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 GE HealthCare Technologies Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 OMRON Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Nonin Medical Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 SunTech Medical Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Masimo Corp
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Contec Medical Systems Co Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Baxter International Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦